Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Matthias Staufenbiel
Based on 51 articles published since 2010
(Why 51 articles?)
||||
Expertise Level
The expertise of Matthias Staufenbiel ranks in the
  • Top 0.5%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 51 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Staufenbiel, M   ·   Staufenbiel, Matthias
Work Locations
Details
Most likely:    Novartis      
2019
  • Laboratory for Neuropathology, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium. · Leuven Brain Institute, KU-Leuven, Leuven, Belgium. · Laboratory for Neuropathology, Institute of Pathology, University of Ulm, Ulm, Germany. · Anasthesiology and Intensive Medicine, University Hospital of Tübingen, Tübingen, Germany. · Department of Gene Therapy, University of Ulm, Ulm, Germany. · Laboratory for the Research of Neurodegenerative Diseases, Department of Neurosciences, KU Leuven (University of Leuven), Leuven, Belgium. · VIB, Center for Brain and Disease Research, Leuven, Belgium. · Department of Neurosciences, KU-Leuven, Leuven, Belgium. · Novartis Institutes for Biomedical Sciences, Basel, Switzerland. · Experimental Neurology Group, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Department of Neurology, UZ-Leuven, Leuven, Belgium. · Department of Neurology, University of Ulm, Ulm, Germany. · Clinic for Neurogeriatrics and Neurological Rehabilitation, University- und Rehabilitation Hospital Ulm (RKU), Ulm, Germany. · Department of Pathology, UZ Leuven, Leuven, Belgium. · Institute for Diabetes and Obesity, Monoclonal Antibody Research Group, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Munich, Germany. · German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany. · Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany. · Chair of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-University Munich, 81377, Munich, Germany. · Laboratory for Neuropathology, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium. · Leuven Brain Institute, KU-Leuven, Leuven, Belgium. · Laboratory for Neuropathology, Institute of Pathology, University of Ulm, Ulm, Germany. · Department of Pathology, UZ Leuven, Leuven, Belgium. · Pubmed 31414210
2018
  • Neuroscience, Novartis Institute for BioMedical Research, Basel, Switzerland · Translational Medicine, Novartis Institute for BioMedical Research, Basel, Switzerland. · Neuroscience, Novartis Institute for BioMedical Research, Basel, Switzerland. · PK Sciences, Novartis Institute for BioMedical Research, Basel, Switzerland. · Preclinical Safety, Novartis Institute for BioMedical Research, Basel, Switzerland. · Global Discovery Chemistry, Novartis Institute for BioMedical Research, Basel, Switzerland. · Biomarker Discovery, Novartis Institute for BioMedical Research, Basel, Switzerland. · Chemical Biology and Therapeutics, Novartis Institute for BioMedical Research, Basel, Switzerland. · Musculoskeletal Diseases, Novartis Institute for BioMedical Research, Basel, Switzerland. · Global Drug Development, Novartis, Basel, Switzerland. · Global Drug Development, Novartis, Basel, Switzerland · Pubmed 30224383
  • Department of Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland. · Center for Proteomic Chemistry, Structural Biology Platform, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland. · Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland. · Department of Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland. Electronic address: · Pubmed 29764741
2016
  • Musculoskeletal Diseases Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Preclinical Safety Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Neuroscience Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Drug Metabolism and Pharmacokinetics Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Neuroscience Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address: · Pubmed 27459925
  • Institute of Pathology, University Hospital Basel, Basel, Switzerland. · Department of Neurology, University Hospital Basel, Basel, Switzerland. · MRC, Laboratory of Molecular Biology, Cambridge, UK. · Institute of Biomedical Research, Novartis Pharma AG, Basel, Switzerland. · Pubmed 26830137
2015
  • Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Metabolism and Pharmacokinetics, NIBR, Basel, Switzerland. · Metabolism and Pharmacokinetics, NIBR, Basel, Switzerland. · DMPK, NIBR, Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Swiss Tropical and Public Health Institute, Basel, Switzerland. · Preclinical Safety, NIBR, Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Melbourne, Australia. · Pubmed 26336937
  • Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Novartis Pharma, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Institute for Pharmaceutical Biotechnology, Center of Biomedical Research, University of Ulm, Ulm, Germany. · Department of Neurology, University of Bonn, Bonn, Germany. · Gunma University School of Health Sciences, Maebashi, Gunma, Japan. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Pubmed 26141728
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Department of Neurology, Hospital de Santo António-CHP, Porto, Portugal · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Institute of Clinical Epidemiology and applied Biostatistics University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany · Pubmed 25978969
  • Dementia Research Unit, Department of Anatomy, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia. · Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Faculty of Medicine, University of New South Wales, Sydney, Australia. · Neuroscience Research Australia, Sydney, Australia. · Discipline of Pathology, University of Sydney, Sydney, Australia. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Sydney Medical School, University of Sydney, Sydney, Australia. · Pubmed 25763777
  • Disease Glycomics Team, RIKEN-Max Planck Joint Research Center Global Research Cluster RIKEN, Wako, Japan. · Disease Glycomics Team, RIKEN-Max Planck Joint Research Center Global Research Cluster RIKEN, Wako, Japan · Laboratory for Proteolytic Neuroscience RIKEN Brain Science Institute, Wako, Japan. · Laboratory for Proteolytic Neuroscience RIKEN Brain Science Institute, Wako, Japan Department of Genome-based Drug Discovery, Unit of Molecular Medicinal Sciences, Graduate School of Biomedical Sciences Nagasaki University, Nagasaki, Japan. · Graduate School of Advanced Sciences of Matter Hiroshima University, Higashihiroshima Hiroshima, Japan. · Structural Glycobiology Team, RIKEN-Max Planck Joint Research Center Global Research Cluster RIKEN, Wako, Japan. · Department of Biochemistry, Fukushima Medical University School of Medicine, Fukushima, Japan. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Department of Neuropathology, Research Team for Mechanism of Aging, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku Tokyo, Japan. · Molecular Glycobiology, Research Team for Mechanism of Aging, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku Tokyo, Japan. · Pubmed 25592972
2014
  • Center for Advanced Therapeutic Strategies for Brain Disorders and. · Novartis Pharm Ltd, Nervous System Research, Basel CH-4002, Switzerland and. · Center for Hormone Advanced Science and Education, The Roskamp Institute, Sarasota, FL 34243, USA, · Center for Advanced Therapeutic Strategies for Brain Disorders and, Department of Neurology, University of Florida College of Medicine, Gainesville FL32610, USA · Pubmed 25027328
  • Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ 85351, USA, Department of Physiology, Medical College of Qingdao University, Qingdao, China. · Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ 85351, USA, Center for Advanced Therapeutic Strategies of Brain Disorders, Roskamp Institute, Sarasota, FL 34243, USA. · Department of Physiology, Medical College of Qingdao University, Qingdao, China. · Novartis Pharma Ltd., Nervous System Research, CH-4002 Basel, Switzerland. · Center for Hormone Advanced Science and Education, Roskamp Institute, Sarasota, FL 34243, USA and · Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ 85351, USA, Department of Physiology, Medical College of Qingdao University, Qingdao, China, Center for Advanced Therapeutic Strategies of Brain Disorders, Roskamp Institute, Sarasota, FL 34243, USA · Pubmed 24824215
2013
  • Department of Global Discovery Chemistry, Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. · Pubmed 23981898
  • Novartis Institutes for Biomedical Research, Basel, Switzerland. Electronic address: · Pubmed 23870837
2012
  • Novartis Institutes for Biomedical Research, CH-4056 Basel, Switzerland. · Pubmed 22279212
2011
  • Novartis Institutes for Biomedical Research, CH-4056 Basel, Switzerland. · Pubmed 21697382
  • Global Imaging Group, Novartis Institutes for BioMedical Research, CH-4056 Basel, Switzerland. · Pubmed 21248127
Probable:    University of Tubingen      
2018
  • German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany. · Department for Systems Medicine and Epigenetics in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Genomics and Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany. · Bioinformatics Unit, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany. · Platform for Single Cell Genomics and Epigenomics at the University of Bonn and the German Center for Neurodegenerative Diseases, Bonn, Germany. · Molecular Immunology in Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 29643512
2017
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany. · German Center for Neurodegenerative Diseases, 72076 Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, 72074 Tübingen, Germany. · Department of Physics, Chemistry and Biology, Division of Chemistry, Linköping University, SE-581 83 Linköping, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, University of Gothenburg, SE-431 80 Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, SE-431 80 Mölndal, Sweden. · Queen Square Brain Bank for Neurological Diseases, Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 1PJ, United Kingdom. · Dementia Research Centre, University College London, London WC1N 3BG, United Kingdom. · Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. · Neuroscience Group of Antioquia, University of Antioquia, 1226 Medellín, Colombia. · Faculty of Medicine, University of Antioquia, 1226 Medellín, Colombia. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202. · Department of Neurology, Emory University, Atlanta, GA 30322. · Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany; · Pubmed 29158413
  • Institute of Neuroscience, Technical University of Munich, 80802 Munich, Germany. · Neuroscience Research, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland. · Institute of Computational Biology, Helmholtz Center Munich, 85764 Munich, Germany. · Department of Psychiatry and Psychotherapy, Technical University of Munich, 81675 Munich, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tuebingen, Germany. · Department of Neurobiology, Silberman Institute of Life Sciences and Edmond and Lily Safra Center for Brain Sciences, Hebrew University of Jerusalem, 91904 Jerusalem, Israel. · Institute of Neuroscience, Technical University of Munich, 80802 Munich, Germany; · Munich Cluster for Systems Neurology, 81377 Munich, Germany. · Pubmed 28739891
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Department of Neurology and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany · Pubmed 28701326
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. · Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. · ADx NeuroSciences, Gent, Belgium. · DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany; CAESAR Research Center, Bonn, Germany. · CAESAR Research Center, Bonn, Germany. · Novartis Institutes for BioMedical Research, Neuroscience, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Pubmed 27750032
2016
  • Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, München, Deutschland. · Institut für Neurowissenschaften, Technische Universität München, München, Deutschland. · Munich Cluster for Systems Neurology (SyNergy), München, Deutschland. · Hertie Institut für Zellbiologie neurologischer Erkrankungen, Universität Tübingen, Tübingen, Deutschland. · BioMedizinisches Zentrum, Ludwig-Maximilians-Universität München, München, Deutschland. · Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) München, München, Deutschland. · Munich Cluster for Systems Neurology (SyNergy), München, Deutschland. · Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, München, Deutschland. · Pubmed 26781314
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), D-72076 Tübingen, Germany. · Max Planck Institute for Developmental Biology, D-72076 Tübingen, Germany. · Pubmed 27311744
2015
  • Institute of Neuroscience, Technische Universität München, Munich, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Munich Cluster for Systems Neurology (SyNergy), München, Germany. · Janelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, Virginia, USA. · Novartis Institute for BioMedical Research, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 26551546
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Yerkes National Primate Research Center and Department of Neurology, Emory University, Atlanta, Georgia, USA. · Pubmed 26352792
  • Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Metabolism and Pharmacokinetics, NIBR, Basel, Switzerland. · Metabolism and Pharmacokinetics, NIBR, Basel, Switzerland. · DMPK, NIBR, Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Swiss Tropical and Public Health Institute, Basel, Switzerland. · Preclinical Safety, NIBR, Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Melbourne, Australia. · Pubmed 26336937
  • Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Novartis Pharma, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Institute for Pharmaceutical Biotechnology, Center of Biomedical Research, University of Ulm, Ulm, Germany. · Department of Neurology, University of Bonn, Bonn, Germany. · Gunma University School of Health Sciences, Maebashi, Gunma, Japan. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Pubmed 26141728
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Department of Neurology, Hospital de Santo António-CHP, Porto, Portugal · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Institute of Clinical Epidemiology and applied Biostatistics University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany · Pubmed 25978969
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Graduate School for Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA; Department of Psychiatry, New York University School of Medicine, New York, NY, USA. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA. · Department of Psychiatry, New York University School of Medicine, New York, NY, USA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Department of Chemistry, IFM, Linköping University, Linköping, Sweden. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Pubmed 25911278
2014
  • German Centre for Neurodegenerative Diseases (DZNE), Tübingen, D-72076 Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, D-72074 Tübingen, Germany. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-43180 Mölndal, Sweden. · Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 3RA, UK. · Department of Neurology and Institute of Pathology, University Hospital Basel, CH-4003 Basel, Switzerland. · Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Institute of Neuropathology, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany. · Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany. · Department of Psychiatry and Psychotherapy, University Medical Centre, D-37075 Göttingen, Germany. · UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK. · Pubmed 25212850
2013
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany, Graduate School for Cellular and Molecular Neuroscience, University of Tübingen, D-72076 Tübingen, Germany, German Center for Neurodegenerative Diseases, D-72076 Tübingen, Germany, and Animal Health and Veterinary Laboratories Agency, Lasswade Laboratory, Penicuik EH26 0PZ, Midlothian, United Kingdom. · Pubmed 24305824
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Pubmed 23863834
2010
  • Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Pubmed 20966215
Probable:    Helmholtz-Gemeinschaft      
2018
  • German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany. · Department for Systems Medicine and Epigenetics in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Genomics and Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany. · Bioinformatics Unit, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany. · Platform for Single Cell Genomics and Epigenomics at the University of Bonn and the German Center for Neurodegenerative Diseases, Bonn, Germany. · Molecular Immunology in Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 29643512
2016
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), D-72076 Tübingen, Germany. · Max Planck Institute for Developmental Biology, D-72076 Tübingen, Germany. · Pubmed 27311744
2015
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Yerkes National Primate Research Center and Department of Neurology, Emory University, Atlanta, Georgia, USA. · Pubmed 26352792
  • Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Novartis Pharma, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Institute for Pharmaceutical Biotechnology, Center of Biomedical Research, University of Ulm, Ulm, Germany. · Department of Neurology, University of Bonn, Bonn, Germany. · Gunma University School of Health Sciences, Maebashi, Gunma, Japan. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Pubmed 26141728
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Department of Neurology, Hospital de Santo António-CHP, Porto, Portugal · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Institute of Clinical Epidemiology and applied Biostatistics University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany · Pubmed 25978969
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Graduate School for Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA; Department of Psychiatry, New York University School of Medicine, New York, NY, USA. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA. · Department of Psychiatry, New York University School of Medicine, New York, NY, USA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Department of Chemistry, IFM, Linköping University, Linköping, Sweden. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Pubmed 25911278
2014
  • German Centre for Neurodegenerative Diseases (DZNE), Tübingen, D-72076 Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, D-72074 Tübingen, Germany. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-43180 Mölndal, Sweden. · Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 3RA, UK. · Department of Neurology and Institute of Pathology, University Hospital Basel, CH-4003 Basel, Switzerland. · Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Institute of Neuropathology, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany. · Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany. · Department of Psychiatry and Psychotherapy, University Medical Centre, D-37075 Göttingen, Germany. · UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK. · Pubmed 25212850
2013
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany, Graduate School for Cellular and Molecular Neuroscience, University of Tübingen, D-72076 Tübingen, Germany, German Center for Neurodegenerative Diseases, D-72076 Tübingen, Germany, and Animal Health and Veterinary Laboratories Agency, Lasswade Laboratory, Penicuik EH26 0PZ, Midlothian, United Kingdom. · Pubmed 24305824
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 51 total) written by Matthias Staufenbiel about Alzheimer Disease:

  • Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein. 2019
  • The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease. 2018
  • Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors. 2018
  • Innate immune memory in the brain shapes neurological disease hallmarks. 2018
  • Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease. 2017
  • BACE inhibition-dependent repair of Alzheimer's pathophysiology. 2017
  • Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis. 2017
  • Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition. 2017
  • [Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets]. 2016
  • Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice. 2016
Show List of Full Article Records
Google Searches

Learn more about Matthias Staufenbiel using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Novartis
University of Tubingen
Helmholtz-Gemeinschaft
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Novartis
2019
  • Laboratory for Neuropathology, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium. · Leuven Brain Institute, KU-Leuven, Leuven, Belgium. · Laboratory for Neuropathology, Institute of Pathology, University of Ulm, Ulm, Germany. · Anasthesiology and Intensive Medicine, University Hospital of Tübingen, Tübingen, Germany. · Department of Gene Therapy, University of Ulm, Ulm, Germany. · Laboratory for the Research of Neurodegenerative Diseases, Department of Neurosciences, KU Leuven (University of Leuven), Leuven, Belgium. · VIB, Center for Brain and Disease Research, Leuven, Belgium. · Department of Neurosciences, KU-Leuven, Leuven, Belgium. · Novartis Institutes for Biomedical Sciences, Basel, Switzerland. · Experimental Neurology Group, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Department of Neurology, UZ-Leuven, Leuven, Belgium. · Department of Neurology, University of Ulm, Ulm, Germany. · Clinic for Neurogeriatrics and Neurological Rehabilitation, University- und Rehabilitation Hospital Ulm (RKU), Ulm, Germany. · Department of Pathology, UZ Leuven, Leuven, Belgium. · Institute for Diabetes and Obesity, Monoclonal Antibody Research Group, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Munich, Germany. · German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany. · Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany. · Chair of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-University Munich, 81377, Munich, Germany. · Laboratory for Neuropathology, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium. · Leuven Brain Institute, KU-Leuven, Leuven, Belgium. · Laboratory for Neuropathology, Institute of Pathology, University of Ulm, Ulm, Germany. · Department of Pathology, UZ Leuven, Leuven, Belgium. · Pubmed 31414210
2018
  • Neuroscience, Novartis Institute for BioMedical Research, Basel, Switzerland · Translational Medicine, Novartis Institute for BioMedical Research, Basel, Switzerland. · Neuroscience, Novartis Institute for BioMedical Research, Basel, Switzerland. · PK Sciences, Novartis Institute for BioMedical Research, Basel, Switzerland. · Preclinical Safety, Novartis Institute for BioMedical Research, Basel, Switzerland. · Global Discovery Chemistry, Novartis Institute for BioMedical Research, Basel, Switzerland. · Biomarker Discovery, Novartis Institute for BioMedical Research, Basel, Switzerland. · Chemical Biology and Therapeutics, Novartis Institute for BioMedical Research, Basel, Switzerland. · Musculoskeletal Diseases, Novartis Institute for BioMedical Research, Basel, Switzerland. · Global Drug Development, Novartis, Basel, Switzerland. · Global Drug Development, Novartis, Basel, Switzerland · Pubmed 30224383
  • Department of Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland. · Center for Proteomic Chemistry, Structural Biology Platform, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland. · Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland. · Department of Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4057 Basel, Switzerland. Electronic address: · Pubmed 29764741
2016
  • Musculoskeletal Diseases Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Preclinical Safety Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Neuroscience Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Drug Metabolism and Pharmacokinetics Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Neuroscience Department, Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address: · Pubmed 27459925
  • Institute of Pathology, University Hospital Basel, Basel, Switzerland. · Department of Neurology, University Hospital Basel, Basel, Switzerland. · MRC, Laboratory of Molecular Biology, Cambridge, UK. · Institute of Biomedical Research, Novartis Pharma AG, Basel, Switzerland. · Pubmed 26830137
2015
  • Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Metabolism and Pharmacokinetics, NIBR, Basel, Switzerland. · Metabolism and Pharmacokinetics, NIBR, Basel, Switzerland. · DMPK, NIBR, Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Swiss Tropical and Public Health Institute, Basel, Switzerland. · Preclinical Safety, NIBR, Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Melbourne, Australia. · Pubmed 26336937
  • Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Novartis Pharma, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Institute for Pharmaceutical Biotechnology, Center of Biomedical Research, University of Ulm, Ulm, Germany. · Department of Neurology, University of Bonn, Bonn, Germany. · Gunma University School of Health Sciences, Maebashi, Gunma, Japan. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Pubmed 26141728
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Department of Neurology, Hospital de Santo António-CHP, Porto, Portugal · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Institute of Clinical Epidemiology and applied Biostatistics University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany · Pubmed 25978969
  • Dementia Research Unit, Department of Anatomy, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia. · Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Faculty of Medicine, University of New South Wales, Sydney, Australia. · Neuroscience Research Australia, Sydney, Australia. · Discipline of Pathology, University of Sydney, Sydney, Australia. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Sydney Medical School, University of Sydney, Sydney, Australia. · Pubmed 25763777
  • Disease Glycomics Team, RIKEN-Max Planck Joint Research Center Global Research Cluster RIKEN, Wako, Japan. · Disease Glycomics Team, RIKEN-Max Planck Joint Research Center Global Research Cluster RIKEN, Wako, Japan · Laboratory for Proteolytic Neuroscience RIKEN Brain Science Institute, Wako, Japan. · Laboratory for Proteolytic Neuroscience RIKEN Brain Science Institute, Wako, Japan Department of Genome-based Drug Discovery, Unit of Molecular Medicinal Sciences, Graduate School of Biomedical Sciences Nagasaki University, Nagasaki, Japan. · Graduate School of Advanced Sciences of Matter Hiroshima University, Higashihiroshima Hiroshima, Japan. · Structural Glycobiology Team, RIKEN-Max Planck Joint Research Center Global Research Cluster RIKEN, Wako, Japan. · Department of Biochemistry, Fukushima Medical University School of Medicine, Fukushima, Japan. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Department of Neuropathology, Research Team for Mechanism of Aging, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku Tokyo, Japan. · Molecular Glycobiology, Research Team for Mechanism of Aging, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku Tokyo, Japan. · Pubmed 25592972
2014
  • Center for Advanced Therapeutic Strategies for Brain Disorders and. · Novartis Pharm Ltd, Nervous System Research, Basel CH-4002, Switzerland and. · Center for Hormone Advanced Science and Education, The Roskamp Institute, Sarasota, FL 34243, USA, · Center for Advanced Therapeutic Strategies for Brain Disorders and, Department of Neurology, University of Florida College of Medicine, Gainesville FL32610, USA · Pubmed 25027328
  • Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ 85351, USA, Department of Physiology, Medical College of Qingdao University, Qingdao, China. · Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ 85351, USA, Center for Advanced Therapeutic Strategies of Brain Disorders, Roskamp Institute, Sarasota, FL 34243, USA. · Department of Physiology, Medical College of Qingdao University, Qingdao, China. · Novartis Pharma Ltd., Nervous System Research, CH-4002 Basel, Switzerland. · Center for Hormone Advanced Science and Education, Roskamp Institute, Sarasota, FL 34243, USA and · Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ 85351, USA, Department of Physiology, Medical College of Qingdao University, Qingdao, China, Center for Advanced Therapeutic Strategies of Brain Disorders, Roskamp Institute, Sarasota, FL 34243, USA · Pubmed 24824215
2013
  • Department of Global Discovery Chemistry, Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. · Pubmed 23981898
  • Novartis Institutes for Biomedical Research, Basel, Switzerland. Electronic address: · Pubmed 23870837
2012
  • Novartis Institutes for Biomedical Research, CH-4056 Basel, Switzerland. · Pubmed 22279212
2011
  • Novartis Institutes for Biomedical Research, CH-4056 Basel, Switzerland. · Pubmed 21697382
  • Global Imaging Group, Novartis Institutes for BioMedical Research, CH-4056 Basel, Switzerland. · Pubmed 21248127
University of Tubingen
2018
  • German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany. · Department for Systems Medicine and Epigenetics in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Genomics and Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany. · Bioinformatics Unit, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany. · Platform for Single Cell Genomics and Epigenomics at the University of Bonn and the German Center for Neurodegenerative Diseases, Bonn, Germany. · Molecular Immunology in Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 29643512
2017
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany. · German Center for Neurodegenerative Diseases, 72076 Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, 72074 Tübingen, Germany. · Department of Physics, Chemistry and Biology, Division of Chemistry, Linköping University, SE-581 83 Linköping, Sweden. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, University of Gothenburg, SE-431 80 Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, SE-431 80 Mölndal, Sweden. · Queen Square Brain Bank for Neurological Diseases, Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 1PJ, United Kingdom. · Dementia Research Centre, University College London, London WC1N 3BG, United Kingdom. · Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. · Neuroscience Group of Antioquia, University of Antioquia, 1226 Medellín, Colombia. · Faculty of Medicine, University of Antioquia, 1226 Medellín, Colombia. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202. · Department of Neurology, Emory University, Atlanta, GA 30322. · Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany; · Pubmed 29158413
  • Institute of Neuroscience, Technical University of Munich, 80802 Munich, Germany. · Neuroscience Research, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland. · Institute of Computational Biology, Helmholtz Center Munich, 85764 Munich, Germany. · Department of Psychiatry and Psychotherapy, Technical University of Munich, 81675 Munich, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tuebingen, Germany. · Department of Neurobiology, Silberman Institute of Life Sciences and Edmond and Lily Safra Center for Brain Sciences, Hebrew University of Jerusalem, 91904 Jerusalem, Israel. · Institute of Neuroscience, Technical University of Munich, 80802 Munich, Germany; · Munich Cluster for Systems Neurology, 81377 Munich, Germany. · Pubmed 28739891
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Department of Neurology and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany · Pubmed 28701326
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. · Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. · ADx NeuroSciences, Gent, Belgium. · DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany; CAESAR Research Center, Bonn, Germany. · CAESAR Research Center, Bonn, Germany. · Novartis Institutes for BioMedical Research, Neuroscience, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Pubmed 27750032
2016
  • Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, München, Deutschland. · Institut für Neurowissenschaften, Technische Universität München, München, Deutschland. · Munich Cluster for Systems Neurology (SyNergy), München, Deutschland. · Hertie Institut für Zellbiologie neurologischer Erkrankungen, Universität Tübingen, Tübingen, Deutschland. · BioMedizinisches Zentrum, Ludwig-Maximilians-Universität München, München, Deutschland. · Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) München, München, Deutschland. · Munich Cluster for Systems Neurology (SyNergy), München, Deutschland. · Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, München, Deutschland. · Pubmed 26781314
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), D-72076 Tübingen, Germany. · Max Planck Institute for Developmental Biology, D-72076 Tübingen, Germany. · Pubmed 27311744
2015
  • Institute of Neuroscience, Technische Universität München, Munich, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Munich Cluster for Systems Neurology (SyNergy), München, Germany. · Janelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, Virginia, USA. · Novartis Institute for BioMedical Research, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 26551546
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Yerkes National Primate Research Center and Department of Neurology, Emory University, Atlanta, Georgia, USA. · Pubmed 26352792
  • Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Global Discover Chemistry, NIBR, Basel, Switzerland. · Metabolism and Pharmacokinetics, NIBR, Basel, Switzerland. · Metabolism and Pharmacokinetics, NIBR, Basel, Switzerland. · DMPK, NIBR, Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Swiss Tropical and Public Health Institute, Basel, Switzerland. · Preclinical Safety, NIBR, Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland. · The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Melbourne, Australia. · Pubmed 26336937
  • Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Novartis Pharma, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Institute for Pharmaceutical Biotechnology, Center of Biomedical Research, University of Ulm, Ulm, Germany. · Department of Neurology, University of Bonn, Bonn, Germany. · Gunma University School of Health Sciences, Maebashi, Gunma, Japan. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Pubmed 26141728
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Department of Neurology, Hospital de Santo António-CHP, Porto, Portugal · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Institute of Clinical Epidemiology and applied Biostatistics University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany · Pubmed 25978969
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Graduate School for Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA; Department of Psychiatry, New York University School of Medicine, New York, NY, USA. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA. · Department of Psychiatry, New York University School of Medicine, New York, NY, USA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Department of Chemistry, IFM, Linköping University, Linköping, Sweden. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Pubmed 25911278
2014
  • German Centre for Neurodegenerative Diseases (DZNE), Tübingen, D-72076 Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, D-72074 Tübingen, Germany. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-43180 Mölndal, Sweden. · Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 3RA, UK. · Department of Neurology and Institute of Pathology, University Hospital Basel, CH-4003 Basel, Switzerland. · Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Institute of Neuropathology, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany. · Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany. · Department of Psychiatry and Psychotherapy, University Medical Centre, D-37075 Göttingen, Germany. · UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK. · Pubmed 25212850
2013
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany, Graduate School for Cellular and Molecular Neuroscience, University of Tübingen, D-72076 Tübingen, Germany, German Center for Neurodegenerative Diseases, D-72076 Tübingen, Germany, and Animal Health and Veterinary Laboratories Agency, Lasswade Laboratory, Penicuik EH26 0PZ, Midlothian, United Kingdom. · Pubmed 24305824
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Pubmed 23863834
2010
  • Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Pubmed 20966215
Helmholtz-Gemeinschaft
2018
  • German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany. · Department for Systems Medicine and Epigenetics in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Genomics and Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany. · Bioinformatics Unit, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany. · Platform for Single Cell Genomics and Epigenomics at the University of Bonn and the German Center for Neurodegenerative Diseases, Bonn, Germany. · Molecular Immunology in Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 29643512
2016
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), D-72076 Tübingen, Germany. · Max Planck Institute for Developmental Biology, D-72076 Tübingen, Germany. · Pubmed 27311744
2015
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Yerkes National Primate Research Center and Department of Neurology, Emory University, Atlanta, Georgia, USA. · Pubmed 26352792
  • Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Novartis Pharma, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Institute for Pharmaceutical Biotechnology, Center of Biomedical Research, University of Ulm, Ulm, Germany. · Department of Neurology, University of Bonn, Bonn, Germany. · Gunma University School of Health Sciences, Maebashi, Gunma, Japan. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Pathology - Laboratory of Neuropathology, Center of Biomedical Research, University of Ulm, Helmholtzstrasse 8/1, D-89081, Ulm, Germany. · Pubmed 26141728
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Department of Neurology, Hospital de Santo António-CHP, Porto, Portugal · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Institute of Clinical Epidemiology and applied Biostatistics University of Tübingen, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany Novartis Institutes for Biomedical Research Neuroscience Discovery Basel, Basel, Switzerland. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany · Pubmed 25978969
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Graduate School for Cellular and Molecular Neuroscience, University of Tübingen, Tübingen, Germany. · Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA; Department of Psychiatry, New York University School of Medicine, New York, NY, USA. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA. · Department of Psychiatry, New York University School of Medicine, New York, NY, USA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Department of Chemistry, IFM, Linköping University, Linköping, Sweden. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. Electronic address: · Pubmed 25911278
2014
  • German Centre for Neurodegenerative Diseases (DZNE), Tübingen, D-72076 Tübingen, Germany. · Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, D-72074 Tübingen, Germany. · Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-43180 Mölndal, Sweden. · Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB2 3RA, UK. · Department of Neurology and Institute of Pathology, University Hospital Basel, CH-4003 Basel, Switzerland. · Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany. · Institute of Neuropathology, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany. · Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, D-45147 Essen, Germany. · Department of Psychiatry and Psychotherapy, University Medical Centre, D-37075 Göttingen, Germany. · UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK. · Pubmed 25212850
2013
  • Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany, Graduate School for Cellular and Molecular Neuroscience, University of Tübingen, D-72076 Tübingen, Germany, German Center for Neurodegenerative Diseases, D-72076 Tübingen, Germany, and Animal Health and Veterinary Laboratories Agency, Lasswade Laboratory, Penicuik EH26 0PZ, Midlothian, United Kingdom. · Pubmed 24305824
16 Other Locations Show
Yearly article counts 013449410745
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.